Literature DB >> 1478664

Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14).

R V Iozzo1, M F Naso, L A Cannizzaro, J J Wasmuth, J D McPherson.   

Abstract

Versican is a major chondroitin sulfate proteoglycan of vascularized connective tissues whose eponym reflects its functional versatility in macromolecular affinity and interactions. In this report we have localized the versican gene (CSPG2) to the long arm of human chromosome 5 by utilizing a combination of somatic cell hybrids, Southern blotting, polymerase chain reaction, and chromosomal in situ hybridization. The proteoglycan gene segregated concordantly with hybrid cell lines containing the long arm of chromosome 5, comprising the 5q12-q14 band regions. To refine this locus further, we screened a chromosome 5-specific library and isolated several genomic clones encoding a portion of the 5' end of versican. One of these genomic clones was used as a probe for in situ hybridization of human chromosome metaphases. The results corroborated the data obtained using somatic cell hybrids and further refined the assignment of the versican gene to the narrow band region of 5q12-5q14, with the primary site likely to be 5q13.2. The availability of novel genomic clones and the mapping data presented here will make possible the identification of any defect genetically linked to this proteoglycan gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478664     DOI: 10.1016/s0888-7543(05)80103-x

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

1.  Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q.

Authors:  M K Wirtz; J R Samples; P L Kramer; K Rust; J R Topinka; J Yount; R D Koler; T S Acott
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 2.  The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.

Authors:  Sumeda Nandadasa; Simon Foulcer; Suneel S Apte
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

3.  Structure of the human aggrecan gene: exon-intron organization and association with the protein domains.

Authors:  W B Valhmu; G D Palmer; P A Rivers; S Ebara; J F Cheng; S Fischer; A Ratcliffe
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

Review 4.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

5.  Selective activation of the versican promoter by epithelial- mesenchymal interactions during hair follicle development.

Authors:  J Kishimoto; R Ehama; L Wu; S Jiang; N Jiang; R E Burgeson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 6.  Versican and the control of inflammation.

Authors:  Thomas N Wight; Inkyung Kang; Mervyn J Merrilees
Journal:  Matrix Biol       Date:  2014-02-07       Impact factor: 11.583

Review 7.  Provisional matrix: A role for versican and hyaluronan.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2016-12-06       Impact factor: 11.583

8.  Assignment of the human aggrecan gene AGC1 to 15q25-->q26.2 by in situ hybridization.

Authors:  W Just; C Klett; U Vetter; W Vogel
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

9.  Mouse aggrecan, a large cartilage proteoglycan: protein sequence, gene structure and promoter sequence.

Authors:  H Watanabe; L Gao; S Sugiyama; K Doege; K Kimata; Y Yamada
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

10.  The synthesis and secretion of versican isoform V3 by mammalian cells: A role for N-linked glycosylation.

Authors:  Ingrid A Harten; Gernot Kaber; Kiran J Agarwal; Inkyung Kang; Sean Reyes Ibarrientos; Gail Workman; Christina K Chan; Mary P Nivison; Nadine Nagy; Kathleen R Braun; Michael G Kinsella; Mervyn J Merrilees; Thomas N Wight
Journal:  Matrix Biol       Date:  2020-01-27       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.